
|Slideshows|August 15, 2019
- Drug Topics August 2019
- Volume 163
- Issue 8
Pharmacy Financial Statements: The Numbers that Count
Author(s)Scotty W. Sykes, CPA, CGMA
Advertisement
Articles in this issue
almost 7 years ago
Reaching a New Generation of Consumersalmost 7 years ago
New Drug Review: Vraylar for Bipolar I Disorderalmost 7 years ago
AI in the Pharmacyalmost 7 years ago
Zolgensma: The $2.1 Million Drugalmost 7 years ago
Physician Dispensing and the Opioid Crisisalmost 7 years ago
Psychotropics for Childrenalmost 7 years ago
Improving the Customer Experiencealmost 7 years ago
Birth Control Services Help Attract and Keep Patientsalmost 7 years ago
Prevalence and Prevention of Sexual Harassment in the Pharmacyalmost 7 years ago
Opinion: Clinician Burnout is Everyone's ProblemAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
3
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
4
AAP Releases 2026-2027 Childhood Flu Recommendations
5


























